Addex Therapeutics Ltd Basic Earnings Loss Per Share
Addex Therapeutics Ltd (ADXN) reported Basic Earnings Loss Per Share of -0.02 CHF/shares for the 3-month period ending 2025-06-30, per its 6-K filed 2025-09-30.
Financial Statements › Income Statement › Earnings Per Share
ifrs-full:BasicEarningsLossPerShare · last filed 2025-09-30
- Addex Therapeutics Ltd basic earnings loss per share for the quarter ending 2025-06-30 was -0.02 CHF/shares, a 115.38% decline year-over-year.
- Addex Therapeutics Ltd basic earnings loss per share for the quarter ending 2024-06-30 was 0.13 CHF/shares.
- Addex Therapeutics Ltd basic earnings loss per share for the quarter ending 2023-06-30 was -0.04 CHF/shares.
- Addex Therapeutics Ltd basic earnings loss per share for the quarter ending 2022-06-30 was -0.19 CHF/shares.
| Period end | Basic Earnings Loss Per Share 3 month | Basic Earnings Loss Per Share 6 month | Basic Earnings Loss Per Share 12 month |
|---|---|---|---|
| 2025-06-30 | -0.02 CHF/shares 6-K · filed 2025-09-30 | -0.03 CHF/shares 6-K · filed 2025-09-30 | |
| 2024-12-31 | 0.07 CHF/shares 20-F · filed 2025-05-15 | ||
| 2024-06-30 | 0.13 CHF/shares 6-K · filed 2025-09-30 | 0.10 CHF/shares 6-K · filed 2025-09-30 | |
| 2023-12-31 | -0.14 CHF/shares 20-F · filed 2025-05-15 | ||
| 2023-06-30 | -0.04 CHF/shares 6-K/A · filed 2023-12-21 | -0.08 CHF/shares 6-K/A · filed 2023-12-21 | |
| 2022-12-31 | -0.46 CHF/shares 20-F · filed 2025-05-15 | ||
| 2022-06-30 | -0.19 CHF/shares 6-K/A · filed 2023-12-21 | -0.34 CHF/shares 6-K/A · filed 2023-12-21 | |
| 2021-12-31 | -0.45 CHF/shares 20-F · filed 2024-04-18 | ||
| 2021-06-30 | -0.14 CHF/shares 6-K/A · filed 2022-09-14 | -0.22 CHF/shares 6-K/A · filed 2022-09-14 | |
| 2020-12-31 | -0.48 CHF/shares 20-F · filed 2023-03-30 | ||
| 2019-12-31 | -0.56 CHF/shares 20-F · filed 2022-03-10 |